... and future Ebola epidemics. The highly customizable nanomedicine cGMP capable pilot scale manufacturing facility in Shelton, CT, will be able to supply all of the nanoviricides drug candidates in quantities needed for human clinical trials. The ...
via Shelton Newswire http://ift.tt/1skS87a
via Shelton Newswire http://ift.tt/1skS87a
No comments:
Post a Comment